Skip to Main Content

Author Details

Zihe Rao
Nankai University
1995
393
69
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36896429The Key Roles of <i>Mycobacterium tuberculosis</i> FadD23 C-terminal Domain in Catalytic Mechanisms.Front Microbiol2023
37488357An intermediate state allows influenza polymerase to switch smoothly between transcription and replication cycles.Nat Struct Mol Biol2023
37542906Structural biology and inhibition of the Mtb cell wall glycoconjugates biosynthesis on the membrane.Curr Opin Struct Biol2023
37322000Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection.Nat Commun2023
37252995Structure of the priming arabinosyltransferase AftA required for AG biosynthesis of <i>Mycobacterium tuberculosis</i>.Proc Natl Acad Sci U S A2023
37244256Structure of the human ATP synthase.Mol Cell2023
37144855Cryo-EM structures of a prokaryotic heme transporter CydDC.Protein Cell2023
37038326Architecture of severe fever with thrombocytopenia syndrome virus.Protein Cell2023
37038286Structure basis for allosteric regulation of lymphocytic choriomeningitis virus polymerase function by Z matrix protein.Protein Cell2023
37098072Structure of the human respiratory complex II.Proc Natl Acad Sci U S A2023
36882106Cryo-EM structures for the Mycobacterium tuberculosis iron-loaded siderophore transporter IrtAB.Protein Cell2023
36898997Structure of the Newcastle Disease Virus L protein in complex with tetrameric phosphoprotein.Nat Commun2023
34687004Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332.Protein Cell2022
35477022Structures of Omicron spike complexes and implications for neutralizing antibody development.Cell Rep2022
35380892Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.Proc Natl Acad Sci U S A2022
35581593Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants.Cell Biosci2022
35729072The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.Annu Rev Biochem2022
36726755High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.Protein Cell2022
36335936A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.Cell2022
35981536Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3.Structure2022
33232691Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.Cell2021
33883698Author Correction: Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation.Nat Microbiol2021
33853951Cryo-EM structure of <i>Mycobacterium smegmatis</i> DyP-loaded encapsulin.Proc Natl Acad Sci U S A2021
33909694Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization.PLoS Pathog2021
33876763Architecture of the mycobacterial succinate dehydrogenase with a membrane-embedded Rieske FeS cluster.Proc Natl Acad Sci U S A2021
33623033Author Correction: Cryo-EM structure of trimeric Mycobacterium smegmatis succinate dehydrogenase with a membrane-anchor SdhF.Nat Commun2021
33864621High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.Protein Cell2021
34819223Structure of <i>Mycobacterium tuberculosis</i> cytochrome <i>bcc</i> in complex with Q203 and TB47, two anti-TB drug candidates.Elife2021
34757795Dual activities of ACC synthase: Novel clues regarding the molecular evolution of <i>ACS</i> genes.Sci Adv2021
34782481Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein.Proc Natl Acad Sci U S A2021
34653416Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex.Cell Rep2021
34535791Structural biology of SARS-CoV-2 and implications for therapeutic development.Nat Rev Microbiol2021
33961621Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.PLoS Biol2021
34143953Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.Cell2021
34031399Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.Nat Commun2021
33976198A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.Nat Commun2021
34330928Cryo-EM structure of mycobacterial cytochrome bd reveals two oxygen access channels.Nat Commun2021
34226547Structural basis for recognition and regulation of arenavirus polymerase L by Z protein.Nat Commun2021
33462575Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M<sup>pro</sup> inhibitors.Chem Commun (Camb)2021
32285350Structures of the portal vertex reveal essential protein-protein interactions for Herpesvirus assembly and maturation.Protein Cell2020
34676096Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2.Natl Sci Rev2020
31939669Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.J Med Chem2020
31758528Structural insights into substrate recognition by the type VII secretion system.Protein Cell2020
32086254Structures of <i>Mycobacterium tuberculosis</i> Penicillin-Binding Protein 3 in Complex with Five <i>β</i>-Lactam Antibiotics Reveal Mechanism of Inactivation.Mol Pharmacol2020
31748385Structural Insight into African Swine Fever Virus dUTPase Reveals a Novel Folding Pattern in the dUTPase Family.J Virol2020
32075933Crystal Structure of African Swine Fever Virus pS273R Protease and Implications for Inhibitor Design.J Virol2020
32041880Structural analysis of a trimeric assembly of the mitochondrial dynamin-like GTPase Mgm1.Proc Natl Acad Sci U S A2020
31942069Host-mediated ubiquitination of a mycobacterial protein suppresses immunity.Nature2020
31972076Identification of Interferon Receptor IFNAR2 As a Novel HCV Entry Factor by Using Chemical Probes.ACS Chem Biol2020
31911601Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10.Nat Commun2020
  • 1 - 50 of 393

Recommended Authors

Thomas Clayton
Celgene/Bristol-Myers Squibb Corporation
Career Start Year 2004
Number of shared co-authors 4
Lester G Carter
Stanford University
Career Start Year 2004
Number of shared co-authors 12
Heath E Klock
Merck & Co., Inc.
Career Start Year 2002
Number of shared co-authors 4
Debanu Das
Accelero Biostructures Inc., USA XPose Therapeutics Inc.
Career Start Year 2001
Number of shared co-authors 6
Maksymilian Chruszcz
University of South Carolina, Michigan State University
Career Start Year 2000
Number of shared co-authors 16
Marc C Deller
Incyte Corporation
Career Start Year 2000
Number of shared co-authors 3
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 9
Henry J Tien
The Scripps Research Institute
Career Start Year 1997
Number of shared co-authors 3
Ashley M Deacon
Accelero Biostructures Inc., USA XPose Therapeutics Inc.
Career Start Year 1996
Number of shared co-authors 5
Clemens Vonrhein
Global Phasing Ltd
Career Start Year 1995
Number of shared co-authors 2
Lukasz Jaroszewski
University of California Riverside School of Medicine
Career Start Year 1995
Number of shared co-authors 10
Diana R Tomchick
University of Texas Southwestern Medical Center
Career Start Year 1993
Number of shared co-authors 1
Stephen Matthews
Imperial College London
Career Start Year 1993
Number of shared co-authors 3
Subbiah Parthasarathy
New York University Grossman School of Medicine
Career Start Year 1990
Number of shared co-authors 14
Wladek Minor
University of Virginia
Career Start Year 1989
Number of shared co-authors 25
Mitchell D Miller
Rice University
Career Start Year 1989
Number of shared co-authors 8
Marc-Andr?? Elsliger
Joint Center for Structural Genomics
Career Start Year 1989
Number of shared co-authors 5
Mark W Knuth
Joint Center for Structural Genomics
Career Start Year 1988
Number of shared co-authors 5
Donald D Lorimer
Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Career Start Year 1986
Number of shared co-authors 12
Ursula Schulze-Gahmen
Gladstone Institute of Virology, Gladstone Institutes San Francisco CA USA .
Career Start Year 1985
Number of shared co-authors 6
Randy J Read
Cambridge Institute for Medical Research, University of Cambridge
Career Start Year 1982
Number of shared co-authors 7
Mamoru Sato
Yokohama City University
Career Start Year 1982
Number of shared co-authors 1
Vladimir N Malashkevich
Albert Einstein College of Medicine
Career Start Year 1982
Number of shared co-authors 9
Tom Alber
University of California berkeley
Career Start Year 1976
Number of shared co-authors 6
Martino Bolognesi
University of Milano
Career Start Year 1975
Number of shared co-authors 4
George N Phillips
Rice University
Career Start Year 1974
Number of shared co-authors 7
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Career Start Year 1971
Number of shared co-authors 5
Wayne A Hendrickson
Columbia University
Career Start Year 1968
Number of shared co-authors 10
Robert M Stroud
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 3
David Eisenberg
university of california los angeles
Career Start Year 1963
Number of shared co-authors 6

Collaborators

David I Stuart
University of Oxford
Co-authored papers 25
Wenqing Xu
Co-authored papers 13
Hualiang Jiang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Co-authored papers 8
Fan Jiang
Co-authored papers 6
Andrzej Joachimiak
Center for Structural Biology of Infectious Diseases, University of Chicago
Co-authored papers 5
Sin Man Lam
Co-authored papers 4
Zhizhi Wang
Co-authored papers 4
Guanghou Shui
Co-authored papers 4
Anthony J Strong
Department of Basic and Clinical Neuroscience, King's College London
Co-authored papers 2
Jarek Meller
Co-authored papers 2
Juha T Huiskonen
Institute of Biotechnology, University of Helsinki
Co-authored papers 2
Chao Shan
Wuhan Institute of Virology, Chinese Academy of Sciences
Co-authored papers 2
Raymond C Stevens
iHuman Institute, ShanghaiTech University
Co-authored papers 2
Rong Xiao
School of Public Health, Capital Medical University
Co-authored papers 1
James E Bray
University of Oxford
Co-authored papers 1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Joel L Sussman
Weizmann Institute of Science
Co-authored papers 1
Sirano Dhe-Paganon
Dana-Farber Cancer Institute
Co-authored papers 1
Mei Jiang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Kristin C Gunsalus
Center for Genomics and Systems Biology, New York University Abu Dhabi (NYUAD)
Co-authored papers 1
Masayori Inouye
Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 1
Gaetano T Montelione
Rensselaer Polytechnic Institute
Co-authored papers 1
Ritu Shastry
Co-authored papers 1
Carol V Robinson
University of Oxford
Co-authored papers 1
Guillaume Lesage
Institute of Molecular Biology, University of Zurich
Co-authored papers 1
Opher Gileadi
Structural Genomics Consortium Karolinska Institute Stockholm Sweden.
Co-authored papers 1
Hongyu Deng
Cancer Research Institute, Central South University
Co-authored papers 1
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 1
Kellie Cunningham
Co-authored papers 1
F W Studier
Brookhaven National Laboratory
Co-authored papers 1
Release 1.2